Peptide record

TPDB00614

Maximin 3 maximin3 Antibacterial Anticancer Antifungal Antioxidant Antiparasitic Antiviral Hemolysis Toxicity standard
27 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB00614
Maximin 3 maximin3
Antibacterial Anticancer Antifungal Antioxidant Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides Functional / health-promoting peptides
AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF pep-lab AFP-GFuse Antifungipept CAFPdb dbAMP 3.0 AI4AVP DRAVP 2.0 APD_complete APD_hemolytic Hemolytic2
standard
No
A 27-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GIGGKILSGLKTALKGAAKELASTYLH
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C122H209N33O35
RNDCQMFPWV
GL
2698.20
10.31
5
1
12
+3
-0.02
0.244
115.93
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
1490
0.55
5
Residue Composition
number
4
A
0
R
0
N
0
D
0
C
1
E
0
Q
5
G
1
H
2
I
5
L
4
K
0
M
0
F
0
P
2
S
2
T
0
W
1
Y
0
V
Amino Acid Distribution
A: 4 R: 0 N: 0 D: 0 C: 0 E: 1 Q: 0 G: 5 H: 1 I: 2 L: 5 K: 4 M: 0 F: 0 P: 0 S: 2 T: 2 W: 0 Y: 1 V: 0
Chemical Descriptors
27 reviewed residue count
C122H209N33O35 sequence-only estimate (linear, free termini)
2698.20 sequence-only estimate (linear, free termini)
10.31 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
-0.02 sequence-only estimate (linear, free termini)
0.244 sequence-only estimate (linear, free termini)
Free Activity
L Activity
Linear Not Available Activity
Free Activity
Antimicrobial Antibacterial Activity
Bombina maxima Activity
Evidence Records 36 records
Evidence 1 Activity

Activity

MIC
Antibacterial
0.9 µg/mL

Target

Escherichia coli ATCC25922

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against E. coli ATCC25922 (MIC 0.9 ug/ml), S. aureus ATCC2592 (MIC 3.1 ug/ml), B. pyocyaneus CMCCB10104 (MIC 1.5 ug/ml), B. megathe
Evidence 2 Activity

Activity

MIC
Antibacterial
3.1 µg/mL

Target

Staphylococcus aureus ATCC2592

Source & Reference

dbAMP DRAMP

Other

Active against E. coli ATCC25922 (MIC 0.9 ug/ml), S. aureus ATCC2592 (MIC 3.1 ug/ml), B. pyocyaneus CMCCB10104 (MIC 1.5 ug/ml), B. megatherium (MIC 0.9 ug/ml), B. dysenterium
Evidence 3 Activity

Activity

MIC
Antibacterial
1.5 µg/mL

Target

B. pyocyaneus CMCCB10104

Source & Reference

dbAMP DRAMP

Other

Active against E. coli ATCC25922 (MIC 0.9 ug/ml), S. aureus ATCC2592 (MIC 3.1 ug/ml), B. pyocyaneus CMCCB10104 (MIC 1.5 ug/ml), B. megatherium (MIC 0.9 ug/ml), B. dysenterium (MIC 0.9 ug/ml), K. pneumoniae (MIC 3.1 u
Evidence 4 Activity

Activity

MIC
Antibacterial
0.9 µg/mL

Target

B. megatherium

Source & Reference

dbAMP DRAMP

Other

0.9 ug/ml), S. aureus ATCC2592 (MIC 3.1 ug/ml), B. pyocyaneus CMCCB10104 (MIC 1.5 ug/ml), B. megatherium (MIC 0.9 ug/ml), B. dysenterium (MIC 0.9 ug/ml), K. pneumoniae (MIC 3.1 ug/ml), and C. albicans ATCC2002
Evidence 5 Activity

Activity

MIC
Antibacterial
0.9 µg/mL

Target

B. dysenterium

Source & Reference

dbAMP DRAMP

Other

MIC 3.1 ug/ml), B. pyocyaneus CMCCB10104 (MIC 1.5 ug/ml), B. megatherium (MIC 0.9 ug/ml), B. dysenterium (MIC 0.9 ug/ml), K. pneumoniae (MIC 3.1 ug/ml), and C. albicans ATCC2002 (MIC 15 uM), A.flavus IFFI4015 (
Evidence 6 Activity

Activity

MIC
Antibacterial
3.1 µg/mL

Target

Klebsiella pneumoniae

Source & Reference

dbAMP DRAMP

Other

CCB10104 (MIC 1.5 ug/ml), B. megatherium (MIC 0.9 ug/ml), B. dysenterium (MIC 0.9 ug/ml), K. pneumoniae (MIC 3.1 ug/ml), and C. albicans ATCC2002 (MIC 15 uM), A.flavus IFFI4015 (ND), and P.uticale IFFI2001 (ND
Evidence 7 Activity

Activity

MIC
Antibacterial
15 µM

Target

Candida albicans ATCC2002

Source & Reference

dbAMP DRAMP

Other

erium (MIC 0.9 ug/ml), B. dysenterium (MIC 0.9 ug/ml), K. pneumoniae (MIC 3.1 ug/ml), and C. albicans ATCC2002 (MIC 15 uM), A.flavus IFFI4015 (ND), and P.uticale IFFI2001 (ND). It also has anti-HIV and spermicida
Evidence 8 Activity

Activity

IC50
IC50=11.4 µg/ml
Anticancer
11.4 µg/mL

Target

Leukemia Cancer
C8166
Blood

Assay & Model

MTT/MTS assay
48-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2001

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation. dbAMP 3.0 classified as Anticancer under the disease-associated peptide function classes.
Evidence 9 Activity

Activity

IC50
IC50 =25.2 µg/ml
Anticancer
25.2 µg/mL

Target

Leukemia Cancer
MOLT-4
Blood

Assay & Model

MTT/MTS assay
48-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2001
Evidence 10 Activity

Activity

IC50
IC50=28 µg/ml
Anticancer
28 µg/mL

Target

Bladder Cancer
BIU-87
Bladder

Assay & Model

MTT/MTS assay
48-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2001
Evidence 11 Activity

Activity

IC50
IC50 =18 µg/ml
Anticancer
18 µg/mL

Target

Bladder Cancer
T-24
Bladder

Assay & Model

MTT/MTS assay
48-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2001
Evidence 12 Activity

Activity

Not Available
Anticancer

Target

Not Available
Not Available
Not Available

Assay & Model

Not Available
Not Available

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2002
Evidence 13 Activity

Activity

MIC
Antifungal
0.9 µg/mL

Target

Escherichia coli ATCC25922

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against E. coli ATCC25922 (MIC 0.9 ug/ml), S. aureus ATCC2592 (MIC 3.1 ug/ml), B. pyocyaneus CMCCB10104 (MIC 1.5 ug/ml), B. megathe
Evidence 14 Activity

Activity

MIC
Antifungal
3.1 µg/mL

Target

Staphylococcus aureus ATCC2592

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against E. coli ATCC25922 (MIC 0.9 ug/ml), S. aureus ATCC2592 (MIC 3.1 ug/ml), B. pyocyaneus CMCCB10104 (MIC 1.5 ug/ml), B. megatherium (MIC 0.9 ug/ml), B. dysenterium
Evidence 15 Activity

Activity

MIC
Antifungal
1.5 µg/mL

Target

B. pyocyaneus CMCCB10104

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against E. coli ATCC25922 (MIC 0.9 ug/ml), S. aureus ATCC2592 (MIC 3.1 ug/ml), B. pyocyaneus CMCCB10104 (MIC 1.5 ug/ml), B. megatherium (MIC 0.9 ug/ml), B. dysenterium (MIC 0.9 ug/ml), K. pneumoniae (MIC 3.1 u
Evidence 16 Activity

Activity

MIC
Antifungal
0.9 µg/mL

Target

B. megatherium

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

0.9 ug/ml), S. aureus ATCC2592 (MIC 3.1 ug/ml), B. pyocyaneus CMCCB10104 (MIC 1.5 ug/ml), B. megatherium (MIC 0.9 ug/ml), B. dysenterium (MIC 0.9 ug/ml), K. pneumoniae (MIC 3.1 ug/ml), and C. albicans ATCC2002
Evidence 17 Activity

Activity

MIC
Antifungal
0.9 µg/mL

Target

B. dysenterium

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

MIC 3.1 ug/ml), B. pyocyaneus CMCCB10104 (MIC 1.5 ug/ml), B. megatherium (MIC 0.9 ug/ml), B. dysenterium (MIC 0.9 ug/ml), K. pneumoniae (MIC 3.1 ug/ml), and C. albicans ATCC2002 (MIC 15 uM), A.flavus IFFI4015 (
Evidence 18 Activity

Activity

MIC
Antifungal
3.1 µg/mL

Target

Klebsiella pneumoniae

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

CCB10104 (MIC 1.5 ug/ml), B. megatherium (MIC 0.9 ug/ml), B. dysenterium (MIC 0.9 ug/ml), K. pneumoniae (MIC 3.1 ug/ml), and C. albicans ATCC2002 (MIC 15 uM), A.flavus IFFI4015 (ND), and P.uticale IFFI2001 (ND
Evidence 19 Activity

Activity

MIC
Antifungal
15 µM

Target

Candida albicans ATCC2002

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

erium (MIC 0.9 ug/ml), B. dysenterium (MIC 0.9 ug/ml), K. pneumoniae (MIC 3.1 ug/ml), and C. albicans ATCC2002 (MIC 15 uM), A.flavus IFFI4015 (ND), and P.uticale IFFI2001 (ND). It also has anti-HIV and spermicida
Evidence 20 Activity

Activity

MIC
Antiparasitic
0.9 µg/mL

Target

Escherichia coli ATCC25922

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets. dbAMP 3.0 classified under the Anti-parasitic function class.
Active against E. coli ATCC25922 (MIC 0.9 ug/ml), S. aureus ATCC2592 (MIC 3.1 ug/ml), B. pyocyaneus CMCCB10104 (MIC 1.5 ug/ml), B. megathe
Evidence 21 Activity

Activity

MIC
Antiparasitic
3.1 µg/mL

Target

Staphylococcus aureus ATCC2592

Source & Reference

dbAMP 3.0 DRAMP

Other

Active against E. coli ATCC25922 (MIC 0.9 ug/ml), S. aureus ATCC2592 (MIC 3.1 ug/ml), B. pyocyaneus CMCCB10104 (MIC 1.5 ug/ml), B. megatherium (MIC 0.9 ug/ml), B. dysenterium
Evidence 22 Activity

Activity

MIC
Antiparasitic
1.5 µg/mL

Target

B. pyocyaneus CMCCB10104

Source & Reference

dbAMP 3.0 DRAMP

Other

Active against E. coli ATCC25922 (MIC 0.9 ug/ml), S. aureus ATCC2592 (MIC 3.1 ug/ml), B. pyocyaneus CMCCB10104 (MIC 1.5 ug/ml), B. megatherium (MIC 0.9 ug/ml), B. dysenterium (MIC 0.9 ug/ml), K. pneumoniae (MIC 3.1 u
Evidence 23 Activity

Activity

MIC
Antiparasitic
0.9 µg/mL

Target

B. megatherium

Source & Reference

dbAMP 3.0 DRAMP

Other

0.9 ug/ml), S. aureus ATCC2592 (MIC 3.1 ug/ml), B. pyocyaneus CMCCB10104 (MIC 1.5 ug/ml), B. megatherium (MIC 0.9 ug/ml), B. dysenterium (MIC 0.9 ug/ml), K. pneumoniae (MIC 3.1 ug/ml), and C. albicans ATCC2002
Evidence 24 Activity

Activity

MIC
Antiparasitic
0.9 µg/mL

Target

B. dysenterium

Source & Reference

dbAMP 3.0 DRAMP

Other

MIC 3.1 ug/ml), B. pyocyaneus CMCCB10104 (MIC 1.5 ug/ml), B. megatherium (MIC 0.9 ug/ml), B. dysenterium (MIC 0.9 ug/ml), K. pneumoniae (MIC 3.1 ug/ml), and C. albicans ATCC2002 (MIC 15 uM), A.flavus IFFI4015 (
Evidence 25 Activity

Activity

MIC
Antiparasitic
3.1 µg/mL

Target

Klebsiella pneumoniae

Source & Reference

dbAMP 3.0 DRAMP

Other

CCB10104 (MIC 1.5 ug/ml), B. megatherium (MIC 0.9 ug/ml), B. dysenterium (MIC 0.9 ug/ml), K. pneumoniae (MIC 3.1 ug/ml), and C. albicans ATCC2002 (MIC 15 uM), A.flavus IFFI4015 (ND), and P.uticale IFFI2001 (ND
Evidence 26 Activity

Activity

MIC
Antiparasitic
15 µM

Target

Candida albicans ATCC2002

Source & Reference

dbAMP 3.0 DRAMP

Other

erium (MIC 0.9 ug/ml), B. dysenterium (MIC 0.9 ug/ml), K. pneumoniae (MIC 3.1 ug/ml), and C. albicans ATCC2002 (MIC 15 uM), A.flavus IFFI4015 (ND), and P.uticale IFFI2001 (ND). It also has anti-HIV and spermicida
Evidence 27 Activity

Activity

MIC
Antiviral
0.9 µg/mL

Target

Escherichia coli ATCC25922

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets. dbAMP 3.0 classified under the Anti-viral function class.
Active against E. coli ATCC25922 (MIC 0.9 ug/ml), S. aureus ATCC2592 (MIC 3.1 ug/ml), B. pyocyaneus CMCCB10104 (MIC 1.5 ug/ml), B. megathe
Evidence 28 Activity

Activity

MIC
Antiviral
3.1 µg/mL

Target

Staphylococcus aureus ATCC2592

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Active against E. coli ATCC25922 (MIC 0.9 ug/ml), S. aureus ATCC2592 (MIC 3.1 ug/ml), B. pyocyaneus CMCCB10104 (MIC 1.5 ug/ml), B. megatherium (MIC 0.9 ug/ml), B. dysenterium
Evidence 29 Activity

Activity

MIC
Antiviral
1.5 µg/mL

Target

B. pyocyaneus CMCCB10104

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Active against E. coli ATCC25922 (MIC 0.9 ug/ml), S. aureus ATCC2592 (MIC 3.1 ug/ml), B. pyocyaneus CMCCB10104 (MIC 1.5 ug/ml), B. megatherium (MIC 0.9 ug/ml), B. dysenterium (MIC 0.9 ug/ml), K. pneumoniae (MIC 3.1 u
Evidence 30 Activity

Activity

MIC
Antiviral
0.9 µg/mL

Target

B. megatherium

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

0.9 ug/ml), S. aureus ATCC2592 (MIC 3.1 ug/ml), B. pyocyaneus CMCCB10104 (MIC 1.5 ug/ml), B. megatherium (MIC 0.9 ug/ml), B. dysenterium (MIC 0.9 ug/ml), K. pneumoniae (MIC 3.1 ug/ml), and C. albicans ATCC2002
Evidence 31 Activity

Activity

MIC
Antiviral
0.9 µg/mL

Target

B. dysenterium

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

MIC 3.1 ug/ml), B. pyocyaneus CMCCB10104 (MIC 1.5 ug/ml), B. megatherium (MIC 0.9 ug/ml), B. dysenterium (MIC 0.9 ug/ml), K. pneumoniae (MIC 3.1 ug/ml), and C. albicans ATCC2002 (MIC 15 uM), A.flavus IFFI4015 (
Evidence 32 Activity

Activity

MIC
Antiviral
3.1 µg/mL

Target

Klebsiella pneumoniae

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

CCB10104 (MIC 1.5 ug/ml), B. megatherium (MIC 0.9 ug/ml), B. dysenterium (MIC 0.9 ug/ml), K. pneumoniae (MIC 3.1 ug/ml), and C. albicans ATCC2002 (MIC 15 uM), A.flavus IFFI4015 (ND), and P.uticale IFFI2001 (ND
Evidence 33 Activity

Activity

MIC
Antiviral
15 µM

Target

Candida albicans ATCC2002

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

erium (MIC 0.9 ug/ml), B. dysenterium (MIC 0.9 ug/ml), K. pneumoniae (MIC 3.1 ug/ml), and C. albicans ATCC2002 (MIC 15 uM), A.flavus IFFI4015 (ND), and P.uticale IFFI2001 (ND). It also has anti-HIV and spermicida
Evidence 34 Activity

Activity

Hemolysis
Hemolysis
50 µg/mL
[Ref:11835991]Little hemolytic activity at 50 µg/ml against red blood cells

Target

red blood cells

Source & Reference

APD_complete APD_hemolytic
DRAMP4
Eur J Immunol. 2005 Apr 35(4):1220-9.##Peptides. 2002 Mar 23(3):427-435.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation.
Evidence 35 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref:11835991]Little hemolytic activity at 50 µg/ml against red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Eur J Immunol. 2005 Apr 35(4):1220-9.##Peptides. 2002 Mar 23(3):427-435.
Evidence 36 Hemolysis

Activity

50 µg/mL
Hemolysis
[Ref:11835991]Little hemolytic activity at 50 µg/ml against red blood cells
Hemolysis

Target

red blood cells

Source & Reference

APD_complete APD_hemolytic
Eur J Immunol. 2005 Apr 35(4):1220-9.##Peptides. 2002 Mar 23(3):427-435.
DRAMP4
APD_complete APD_hemolytic